PLoS ONE (Jan 2014)

Single nucleotide polymorphisms with cis-regulatory effects on long non-coding transcripts in human primary monocytes.

  • Jonas Carlsson Almlöf,
  • Per Lundmark,
  • Anders Lundmark,
  • Bing Ge,
  • Tomi Pastinen,
  • Cardiogenics Consortium,
  • Alison H Goodall,
  • François Cambien,
  • Panos Deloukas,
  • Willem H Ouwehand,
  • Ann-Christine Syvänen

DOI
https://doi.org/10.1371/journal.pone.0102612
Journal volume & issue
Vol. 9, no. 7
p. e102612

Abstract

Read online

We applied genome-wide allele-specific expression analysis of monocytes from 188 samples. Monocytes were purified from white blood cells of healthy blood donors to detect cis-acting genetic variation that regulates the expression of long non-coding RNAs. We analysed 8929 regions harboring genes for potential long non-coding RNA that were retrieved from data from the ENCODE project. Of these regions, 60% were annotated as intergenic, which implies that they do not overlap with protein-coding genes. Focusing on the intergenic regions, and using stringent analysis of the allele-specific expression data, we detected robust cis-regulatory SNPs in 258 out of 489 informative intergenic regions included in the analysis. The cis-regulatory SNPs that were significantly associated with allele-specific expression of long non-coding RNAs were enriched to enhancer regions marked for active or bivalent, poised chromatin by histone modifications. Out of the lncRNA regions regulated by cis-acting regulatory SNPs, 20% (n = 52) were co-regulated with the closest protein coding gene. We compared the identified cis-regulatory SNPs with those in the catalog of SNPs identified by genome-wide association studies of human diseases and traits. This comparison identified 32 SNPs in loci from genome-wide association studies that displayed a strong association signal with allele-specific expression of non-coding RNAs in monocytes, with p-values ranging from 6.7×10(-7) to 9.5×10(-89). The identified cis-regulatory SNPs are associated with diseases of the immune system, like multiple sclerosis and rheumatoid arthritis.